Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04005417 · ClinicalTrials.gov registry record
Meta-analysis of Stannous Fluoride Dentifrice and the Effects on Dentine Hypersensitivity
A clinical trial of Dentine Hypersensitivity, sponsored by Procter and Gamble.
- Completed
- Registry status
- 1,036
- Enrollment target
- 1
- Study location
NCT04005417 is a study of Dentine Hypersensitivity that has completed, run by Procter and Gamble. The registered enrollment target is 1,036 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04005417, a study of Dentine Hypersensitivity, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- 1,036 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this 11 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) on dentine hypersensitivity versus a positive or negative control dentifrice.
Conditions Studied
Interventions
- DRUG Stannous fluoride dentifrice
- DRUG Positive control dentifrice
- DRUG Negative control dentifrice
Study Locations (1)
Ohio
- Multiple P&G Investigation Clinical Sites - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,036 participants |
| Start Date | 2018-01-08 |
| Est. Completion | 2018-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04005417
The ClinicalTrials.gov registry entry for NCT04005417 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,036 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dentine Hypersensitivity appearing as the primary indexed condition, and to 3 interventions - of which Stannous fluoride dentifrice is the first listed.
NCT04005417 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04005417 about?
NCT04005417 is a clinical study titled "Meta-analysis of Stannous Fluoride Dentifrice and the Effects on Dentine Hypersensitivity". The aim of this 11 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) on dentine hypersensitivity versus a positive or negative control dentifrice.
What is the current status of trial NCT04005417?
This trial is currently completed. The enrollment target is 1,036 participants. The study started on 2018-01-08. Estimated completion is 2018-11-30.
What conditions does trial NCT04005417 study?
This clinical trial studies the following conditions: Dentine Hypersensitivity.
What interventions are being tested in trial NCT04005417?
The interventions under investigation include: Stannous fluoride dentifrice (DRUG), Positive control dentifrice (DRUG), Negative control dentifrice (DRUG).
Who is sponsoring clinical trial NCT04005417?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04005417 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.